Biodexa Pharmaceuticals annual debt-to-assets ratio
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Biodexa Pharmaceuticals Debt-to-Assets Ratio Growth & History (BDRX)
Biodexa Pharmaceuticals's debt-to-assets ratio was 0.00 for fiscal 2025.
View full Biodexa Pharmaceuticals company overviewBiodexa Pharmaceuticals annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.00 | −0.04 | −91.86% |
| 2024 | 2024-12-31 | 0.04 | 0.03 | +157.03% |
| 2023 | 2023-12-31 | 0.02 | −0.01 | −44.99% |
| 2022 | 2022-12-31 | 0.03 | 0.02 | +157.73% |
| 2021 | 2021-12-31 | 0.01 | −0.01 | −44.50% |
| 2020 | 2020-12-31 | 0.02 | 0.01 | +52.77% |
| 2019 | 2019-12-31 | 0.01 | −0.06 | −81.85% |
| 2018 | 2018-12-31 | 0.07 | −0.06 | −44.75% |
| 2017 | 2017-12-31 | 0.13 | 0.09 | +249.34% |
| 2016 | 2016-12-31 | 0.04 | 0.01 | +25.02% |
| 2015 | 2015-12-31 | 0.03 | — | — |
Biodexa Pharmaceuticals quarterly debt-to-assets ratio
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.00 | −0.04 | −91.86% |
| Q2 2025 | 2025-06-30 | 0.03 | 0.02 | +171.30% |
| Q4 2024 | 2024-12-31 | 0.04 | 0.03 | +157.03% |
| Q2 2024 | 2024-06-30 | 0.01 | −0.01 | −39.52% |
| Q4 2023 | 2023-12-31 | 0.02 | −0.01 | −44.99% |
| Q2 2023 | 2023-06-30 | 0.02 | — | — |
| Q4 2022 | 2022-12-31 | 0.03 | 0.02 | +157.73% |
| Q4 2021 | 2021-12-31 | 0.01 | −0.01 | −44.50% |
| Q4 2020 | 2020-12-31 | 0.02 | 0.01 | +52.77% |
| Q4 2019 | 2019-12-31 | 0.01 | −0.06 | −81.85% |
| Q4 2018 | 2018-12-31 | 0.07 | — | — |
Biodexa Pharmaceuticals debt-to-assets ratio trends
Over the last five fiscal years, Biodexa Pharmaceuticals's debt-to-assets ratio decreased from 0.02 to 0.00, a change of −0.02. The latest reported quarter, Q4 2025, shows 0.00.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biodexa Pharmaceuticals source filings ↗Community posts
Biodexa advances trial enrollment as research spending and cash use rise
Biodexa ($BDRX) reported that 92 of the planned 168 participants have entered its Serenta trial, while first-half research and development spending increased to £2.92 million from £1.67 million. Spending reflected the trial and manufacturin ...